Novavax analyst ratings
WebSep 8, 2024 · In recent trading, shares of Novavax, Inc. (Symbol: NVAX) have crossed above the average analyst 12-month target price of $264.20, changing hands for $270.58/share. When a stock reaches the target ... Web2 days ago · Novavax's Q4 revenue increased 61% year-over-year to $357 million, which missed average analyst estimates of $383.14 million. In its 10K filing, the company said …
Novavax analyst ratings
Did you know?
WebJan 2, 2024 · HC Wainwright & Co. has decided to maintain its Buy rating of Novavax (NASDAQ:NVAX) and lower its price target from $207.00 to $110.00. Shares of Novavax are trading up 5.76% over the last 24 ... WebApr 15, 2024 · Novavax, Inc. (NASDAQ:NVAX – Get Rating) has earned a consensus recommendation of “Hold” from the nine analysts that are presently covering the firm, MarketBeat.com reports. Three analysts have rated the stock with a sell recommendation, two have issued a hold recommendation and two have assigned a buy recommendation …
WebApr 15, 2024 · Novavax, Inc. (NASDAQ:NVAX – Get Rating) – Analysts at Zacks Research upped their FY2025 earnings estimates for shares of Novavax in a research report issued to clients and investors on ... WebApr 10, 2024 · Novavax stock opened at $8.46 on Monday. The business’s 50 day simple moving average is $8.21 and its 200 day simple moving average is $13.52. Novavax has a 12 month low of $5.61 and a 12 month ...
WebApr 13, 2024 · Novavax's Q4 revenue increased 61% year-over-year to $357 million, which missed average analyst estimates of $383.14 million. In its 10K filing, the company said the U.S. government did not... WebApr 15, 2024 · Novavax, Inc. (NASDAQ:NVAX – Get Rating) has earned an average rating of “Hold” from the nine brokerages that are currently covering the stock, Marketbeat.com reports.Three equities research analysts have rated the stock with a sell recommendation, two have given a hold recommendation and two have issued a buy recommendation on …
WebJan 29, 2024 · Novavax, Inc. NVAX shares were roaring higher Friday after the company reported topline results from the late-stage trial of its coronavirus vaccine candidate in the U.K. The Novavax Analyst:...
WebApr 15, 2024 · Novavax, Inc. (NASDAQ:NVAX – Get Rating) – Equities research analysts at Zacks Research increased their FY2025 earnings per share (EPS) estimates for shares of … clinica sao jose boituva spWebApr 5, 2024 · According to the issued ratings of 6 analysts in the last year, the consensus rating for Novavax stock is Hold based on the current 2 sell ratings, 2 hold ratings and 2 … clinica sao lazaro ibotiramaWebFeb 1, 2024 · Feb 1, 2024 8:44AM EST. I n recent trading, shares of Novavax, Inc. (Symbol: NVAX) have crossed above the average analyst 12-month target price of $208.00, changing hands for $220.94/share. When a ... targets ks2WebApr 12, 2024 · A number of research analysts have commented on NVAX shares. StockNews.com started coverage on Novavax in a research report on Thursday, March 16th. They issued a "sell" rating on the stock. HC Wainwright reiterated a "buy" rating and issued a $110.00 price objective on shares of Novavax in a research report on Monday, February … targets online omaha neWebApr 15, 2024 · Novavax Shares Jumped in January While Others Slipped; Novavax, Inc. (NASDAQ:NVAX - Get Rating) - Investment analysts at Zacks Research lifted their FY2025 earnings estimates for shares of Novavax in a research note issued on Tuesday, April 11th.Zacks Research analyst S. Ganoria now forecasts that the biopharmaceutical … targets sales adWeb18 hours ago · Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. clinica sao lazaro jfWebJun 8, 2024 · after a regulatory panel approved Novavax’s Emergency Use Authorization request for Nuvaxovid, its COVID vaccine. Here's what investors need to know. The Novavax Analyst: Bank of America... targets swimming pools